Stockreport

PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy

PaxMedica, Inc.  (PXMD) 
PDF TARRYTOWN, New York, May 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (OTC:PXMD), a biopharmaceutical company focused on advancing treatments for neurologic [Read more]